Solius Labs’ Solius Pro Earns First FDA OTC UVB Category with 510(k) Clearance to Stimulate Vitamin D
Solius Labs launched Solius Pro, the first over-the-counter UVB light panel cleared by the FDA to stimulate the body’s vitamin D production without tanning, prompting the agency to create a new product code. The device is Class II 510(k)-cleared for a narrow indication distinct from clinic UVB treatments and tanning beds.
Solius Labs Launches FDA-Cleared Personalized UVB Device to Combat Vitamin D Deficiency at Home
Solius Labs has launched Solius Pro, an FDA-cleared at-home UVB light device that personalizes vitamin D therapy based on individual skin analysis to safely combat widespread vitamin D deficiency in the U.S. The device delivers weekly, controlled UVB doses through a user app, providing a safe alternative to sun exposure.
Solius Labs Raises $23M Series A to Launch FDA-Cleared $2,995 At-Home UVB Light Therapy Device
Solius Labs, a Bainbridge Island startup founded in 2013, raised $23 million in Series A funding to launch the Solius Pro, a $2,995 FDA-cleared at-home UVB light therapy device that delivers safe, personalized vitamin D stimulating treatment via a smartphone-controlled wall-mounted unit. The device uses a patented skin-scanning sensor to customize UVB dosage in under five minutes per weekly session, enabling convenient home use previously only available in clinics.
See all 5 stories, episodes and videos about Chris Kiple.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
Organizations
-
Solius Labs Executive Officer, Director 2026–present, Chief Executive Officer · current